Home  »  Business   »  Buy or Sell VistaGen Therapeutics Inc. (VTGN) Stoc...

Buy or Sell VistaGen Therapeutics Inc. (VTGN) Stock Now | Don’t Try to Be a Top Gun

VistaGen Therapeutics Inc. (NASDAQ:VTGN) went up by 10.38% from its latest closing price compared to the recent 1-year high of $1.79. The company’s stock price has collected 8.49% of gains in the last five trading sessions.

Is It Worth Investing in VistaGen Therapeutics Inc. (NASDAQ :VTGN) Right Now?

Plus, the 36-month beta value for VTGN is at 0.62. Opinions of the stock are interesting as 0 analysts out of 3 who provided ratings for VistaGen Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 0 as “sell.”

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


The average price from analysts is $0.25. VTGN currently public float of 205.00M and currently shorts hold a 7.53% ratio of that float. Today, the average trading volume of VTGN was 5.98M shares.

VTGN’s Market Performance

VTGN stocks went up by 8.49% for the week, with a monthly jump of 57.64% and a quarterly performance of 52.31%, while its annual performance rate touched -89.43%. The volatility ratio for the week stands at 13.95% while the volatility levels for the past 30 days are set at 16.21% for VistaGen Therapeutics Inc. The simple moving average for the period of the last 20 days is 27.88% for VTGN stocks with a simple moving average of -66.68% for the last 200 days.

VTGN Trading at 29.32% from the 50-Day Moving Average

After a stumble in the market that brought VTGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.44% of loss for the given period.

Volatility was left at 16.21%, however, over the last 30 days, the volatility rate increased by 13.95%, as shares surge +62.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +30.49% upper at present.

During the last 5 trading sessions, VTGN rose by +8.49%, which changed the moving average for the period of 200-days by -86.41% in comparison to the 20-day moving average, which settled at $0.1372. In addition, VistaGen Therapeutics Inc. saw 66.21% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at VTGN starting from GIN JERRY B, who purchase 100,000 shares at the price of $0.18 back on Aug 18. After this action, GIN JERRY B now owns 100,000 shares of VistaGen Therapeutics Inc., valued at $17,870 using the latest closing price.

GIN JERRY B, the Director of VistaGen Therapeutics Inc., purchase 100,000 shares at $0.18 during a trade that took place back on Aug 18, which means that GIN JERRY B is holding 100,000 shares at $17,870 based on the most recent closing price.

Stock Fundamentals for VTGN

Current profitability levels for the company are sitting at:

  • -4308.68 for the present operating margin
  • +26.49 for the gross margin

The net margin for VistaGen Therapeutics Inc. stands at -4307.19. Equity return is now at value -117.40, with -97.80 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 12.29.